Back to JANX
GOLDMAN SACHS GROUP INC → JANX
GOLDMAN SACHS GROUP INC JANX Position History
Janux Therapeutics, Inc. • Healthcare
Quarters held
12
Latest value
$1.8M
Q2 2026
Peak value
$14.2M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $7.1M |
| Q2 2025 | $955K |
| Q3 2025 | $14M |
| Q3 2025 | $2M |
| Q4 2025 | $613K |
| Q4 2025 | $14.2M |
| Q4 2025 | $14.2M |
| Q4 2025 | $613K |
| Q1 2026 | $7M |
| Q1 2026 | $1.4M |
| Q2 2026 | $12.9M |
| Q2 2026 | $1.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $1.8M | 116.1K | — | — |
| Q2 2026 | $12.9M | 836.6K | — | — |
| Q1 2026 | $1.4M | 97.4K | — | — |
| Q1 2026 | $7M | 504.7K | — | — |
| Q4 2025 | $613K | 44.4K | — | — |
| Q4 2025 | $14.2M | 1.03M | — | — |
| Q4 2025 | $14.2M | 1.03M | — | — |
| Q4 2025 | $613K | 44.4K | — | — |
| Q3 2025 | $2M | 82.7K | — | — |
| Q3 2025 | $14M | 572.4K | — | — |
| Q2 2025 | $955K | 41.3K | — | — |
| Q2 2025 | $7.1M | 307.2K | — | — |